Skip to content

Robin Holland

My feedback

2 results found

  1. 2 votes

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
  2. 1 vote

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)

    We’ll send you updates on this idea

    How important is this to you?

    We're glad you're here

    Please sign in to leave feedback

    Signed in as (Sign out)
    An error occurred while saving the comment
    Robin Holland commented  · 

    In a standout deal, Spartan Capital closed a $69 million IPO for Aimei Health Technology, a biopharmaceutical and medical technology startup. Despite a “frozen” IPO market, as Lowry described, Spartan’s strategic selection of high-potential companies of magazines https://getthismagazine.com/ and robust investor network enabled the deal’s success. This transaction reinforced Spartan’s ability to defy market headwinds, positioning it as a leader in SPAC and biotech IPOs.

Feedback and Knowledge Base